Publication | Closed Access

Quantitative bioanalytical assay for the human epidermal growth factor receptor (HER) inhibitor dacomitinib in rat plasma by UPLC-MS/MS

Inhibitor DacomitinibMedicineQuantitative Bioanalytical AssayCancer GrowthTherapeutic EfficacyFibroblast Growth FactorPharmacotherapyAnti-cancer AgentDermatologyPharmacologyRat PlasmaDrug Discovery